Trademarkia Logo

Canada

C$
R DESIGN
REGISTERED

on 22 Jul 2019

Last Applicant/ Owned by

REVANCE THERAPEUTICS INC.

7555 Gateway Blvd.Newark, CA 94560

US

Serial Number

1795520 filed on 11th Aug 2016

Registration Number

TMA1043384 registered on 22nd Jul 2019

Registration expiry Date

22nd Jul 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

R DESIGN

Trademark usage description

pharmaceutical preparations for the treatment of neurological disorders, namely, involuntary movement, spasticity, rigidity, pain, affective disorders Read More

Vienna Information


26 . 4 . 1

SquaresCarrés

26 . 4 . 2

RectanglesRectangles

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 21

One letterUne lettre

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of neurological disorders, namely, involuntary movement, spasticity, rigidity, pain, affective disorders, and sleep disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments or bone, cerebral palsy, muscle spasms, muscle tremors and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, intractable pain, labor pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, namely, involuntary movement, spasticity, rigidity, pain, affective disorders, and sleep disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments or bone, cerebral palsy, muscle spasms, muscle tremors and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, intractable pain, labor pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; body creams, lotions and gels for medical purposes, namely, for skin hydration, rehydration and anti-wrinkle purposes; eye creams, lotions and gels for medical purposes, namely, for skin hydration, rehydration and anti-wrinkle purposes


Classification kind code

10

Class [042]
Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; medical and scientific research namely therapeutic and aesthetic applications of neurotoxins; performing measurement evaluations in the field of facial wrinkles and lateral canthal lines; research and development of drug delivery methods in the field of medicine; conducting and evaluating medical and scientific research and clinical trials in the fields of dermatology


Classification kind code

10

Mark Details


Serial Number

1795520

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 26th Apr 2019
Allowed
Submitted for opposition 42
on 9th Jan 2019
Advertised
Submitted for opposition 26
on 20th Dec 2018
Approved
Submitted for opposition 27
on 29th Oct 2018
Approval Notice Sent
Submitted for opposition 12
on 12th Dec 2017
Extension of Time
Submitted for opposition 22
on 19th Jun 2017
Search Recorded
Submitted for opposition 20
on 19th Jun 2017
Examiner's First Report
Submitted for opposition 31
on 16th Aug 2016
Formalized
Submitted for opposition 1
on 12th Aug 2016
Created
Submitted for opposition 30
on 11th Aug 2016
Filed